NEW YORK (360Dx) – March was a mixed month for the 360Dx Index as 10 of the 26 firms in the index saw their stock prices drop month over month.

Overall, the index was up almost 2 percent, paced by Foundation Medicine and Enzo Biochem, each of which saw their share prices finish about 30 percent up last month. NantHealth (-35 percent) paced the decliners.

The index managed to beat the broader markets, as the Dow Jones Industrial Average was down .7 percent, while the Nasdaq Composite was up a little more than 1 percent, and the Nasdaq Biotech finished March down 1 percent.